Studies have reported that broadly neutralizing antibodies (Abs) have immense potential as antiviral therapeutic agents due to their capability to identify highly conserved epitopes seldom mutated in ...
Secondary primary malignancies (SPMs) with CAR-T cell therapy in RR-DLBCL from real-world data. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback